​
​

Kala Pharmaceuticals Ownership | Who Owns Kala Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

Kala Pharmaceuticals Ownership Summary

5.14% insiders, and 94.86% retail investors. Parallel advisors is the largest institutional shareholder, holding 0% of KALA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.57% of its assets in Kala Pharmaceuticals shares.

KALA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKala Pharmaceuticals-5.14%94.86%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.80%9.10%56.10%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Parallel advisors1.00-$7.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Parallel advisors1.00-$7.00

Top Buyers

HolderShares% AssetsChange
Parallel advisors1.00--

Top Sellers

HolderShares% AssetsChange
Parallel advisors1.00--

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241-1-------
Mar 31, 20241-1-------
Dec 31, 20231-1-------
Sep 30, 20231-66.67%1-99.06%-160.78%--100.00%--
Jun 30, 2023350.00%106863.64%-1927280.00%1---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv26.44K0.57%-
Vanguard Institutional Extnd Mkt Idx Tr26.30K0.57%-
Fidelity Extended Market Index21.29K0.46%9.97K
Vifag 2002 SICAV20.00K0.43%-
BlackRock Extended Equity Market K9.24K0.20%-4.00
Fidelity Total Market Index8.38K0.18%6.15K
Fidelity Series Total Market Index5.00K0.11%2.48K
NT Ext Equity Mkt Idx Fd - L2.64K0.06%-
Northern Trust Extended Eq Market Idx2.64K0.06%-
Fidelity Nasdaq Composite Index1.48K0.03%-

Recent Insider Transactions

DateNameRoleActivityValue
Jun 26, 2024Bazemore Todd SEE REMARKSSell$22.10K
Jun 26, 2024Kharabi Darius CHIEF BUSINESS OFFICERSell$24.50K
Jun 26, 2024Reumuth Mary CHIEF FINANCIAL OFFICERSell$19.77K
Jun 26, 2024Iwicki Mark T CHIEF EXECUTIVE OFFICERSell$72.05K
Jun 26, 2024Brazzell Romulus K SEE REMARKSSell$26.07K

Insider Transactions Trends

DateBuySell
2024 Q2-10
2024 Q1-6
2023 Q2--
2023 Q1-5
2022 Q4-5

KALA Ownership FAQ

Who Owns Kala Pharmaceuticals?

Kala Pharmaceuticals shareholders are primarily institutional investors at 0%, followed by 5.14% insiders and 0% retail investors. The average institutional ownership in Kala Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.80%, which Kala Pharmaceuticals falls below.

Does Blackrock own Kala Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Kala Pharmaceuticals.

Who is Kala Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Parallel advisors is Kala Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 1 Kala Pharmaceuticals shares, valued at 7$.

Who is the top mutual fund holder of Kala Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Kala Pharmaceuticals shares, with 0.57% of its total shares outstanding invested in 26.44K Kala Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools